No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
1 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
[2] VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
2 | Bladder cancer 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
3 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
4 | EGFR tyrosine kinase inhibitor resistance 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
5 | Fluid shear stress and atherosclerosis 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
6 | Focal adhesion 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
[1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
7 | Gastric acid secretion 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
8 | HIF-1 signaling pathway 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
9 | Human cytomegalovirus infection 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
10 | Human papillomavirus infection 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
11 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
12 | MAPK signaling pathway 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
[1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
13 | Metabolic pathways 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
14 | MicroRNAs in cancer 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
15 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
16 | Pancreatic cancer 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
17 | Pathways in cancer 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
[1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
18 | PI3K-Akt signaling pathway 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
[1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
19 | Proteoglycans in cancer 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
20 | Rap1 signaling pathway 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
[1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
21 | Ras signaling pathway 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
[1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
22 | Relaxin signaling pathway 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
[2] VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
23 | Renal cell carcinoma 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
24 | Rheumatoid arthritis 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
25 | VEGF signaling pathway 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |